A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02186925

Enrollment

1000

Registered

2014-07-10

Start date

2014-08-31

Completion date

2025-08-31

Last updated

2015-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Kidney Cancer, Prostate Cancer

Keywords

Kidney Cancer, Prostate Cancer, Bladder Cancer

Brief summary

Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age.

Exclusion criteria

* Patients under the age of 18

Design outcomes

Primary

Measure	Time frame	Description
Progression Free Survival	5 years	Univariate analysis will be used to assess the effects of clinical factors on progression free survival.

Secondary

Measure	Time frame	Description
Patient overall survival	5 years	Univariate analysis will be used to assess the effects of clinical factors on overall survival.

Countries

Israel

Contacts

Primary ContactDaniel Kejzman, MD

daniel.kejzman@clalit.org.il00972-9747-1606

Outcome results